| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/05/2006 | EP1641784A1 4-(aminomethyl)-piperidine benzamides as 5ht4 -antagonists |
| 04/05/2006 | EP1641783A1 Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists |
| 04/05/2006 | EP1641780A1 Processes for the preparation of 1- [(benzoimidazole-1yl) quinolin-8-yl] piperidin-4-ylamine derivatives |
| 04/05/2006 | EP1641779A1 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator. |
| 04/05/2006 | EP1641777A1 Indole derivatives with apoptosis-inducing effect |
| 04/05/2006 | EP1641776A1 Novel piperidine derivatives |
| 04/05/2006 | EP1641771A1 Hydroxamate sulfonamides as cd23 shedding inhibitors |
| 04/05/2006 | EP1641767A2 Bicyclic heterocycles, drugs containing said compounds, the use thereof and method for preparing the same |
| 04/05/2006 | EP1641766A2 Novel chemical compounds |
| 04/05/2006 | EP1641762A2 Cck-1 receptor modulators |
| 04/05/2006 | EP1641761A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 04/05/2006 | EP1641760A2 Novel tetrahydroquinolines |
| 04/05/2006 | EP1641757A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 04/05/2006 | EP1641748A2 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer s disease |
| 04/05/2006 | EP1641744A2 Crystalline form of b2 adrenergic receptor agonist |
| 04/05/2006 | EP1641741A1 Levalbuterol hydrochloride polymorph b |
| 04/05/2006 | EP1641535A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 04/05/2006 | EP1641492A2 Controlled platelet activation to monitor therapy of adp antagonists |
| 04/05/2006 | EP1641489A1 Prolyl oligopeptidase inhibitors ameliorating recovery from brain trauma |
| 04/05/2006 | EP1641485A1 Inhibition of sars coronavirus infection with clinically approved antiviral drugs |
| 04/05/2006 | EP1641480A1 Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent |
| 04/05/2006 | EP1641478A1 Herbal compositions for the treatment and prevention of prostate disorders |
| 04/05/2006 | EP1641476A2 Use of an antioxidant in a dermatological and/or cosmetic composition |
| 04/05/2006 | EP1641473A1 Buffered compositions for dialysis |
| 04/05/2006 | EP1641470A1 Vaginal compositions for treating pelvic tissue infections and traumas |
| 04/05/2006 | EP1641469A1 Aivlosin for the treatment of disease due to brachyspira pilosicoli or ornithobacterium rhinotracheale |
| 04/05/2006 | EP1641468A2 Use of s1p |
| 04/05/2006 | EP1641467A1 (20s)-1alpha-hydroxy-2-methylene-19-nor-vitamin d3 and its uses |
| 04/05/2006 | EP1641465A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
| 04/05/2006 | EP1641464A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 04/05/2006 | EP1641463A1 Compositions in the form of a spray comprising a pharmaceutical agent at least one volatile silicone and a non-volatile oily phase |
| 04/05/2006 | EP1641462A1 Enteric coated composition comprising prostaglandin analogs as chloride channel opener |
| 04/05/2006 | EP1641461A1 COMBINATION PRODUCT COMPRISING AN ANTAGONIST OR INVERSE AGONIST OF HISTAMINE RECEPTOR H<SB>3</SB>AND AN ANTIPSYCHOTIC OR ANTIDEPRESSANT AGENT, AND USE THEREOF FOR THE PREPARATION OF A MEDICAMENT THAT PREVENTS THE ADVERSE EFFECTS OF PSYCHOTROPIC DRUGS |
| 04/05/2006 | EP1641460A2 Stable 5, 10-methylene-tetrahydrofolate pharmaceutical compounds |
| 04/05/2006 | EP1641459A1 Use of osmolytes obtained from extremophilic bacteria for producing medicaments for the external treatment of neurodermatitis |
| 04/05/2006 | EP1641458A2 Pharmaceutical combinations of phthalazine vegf inhibitors and benzamide hdac inhibitors |
| 04/05/2006 | EP1641457A1 Pyrrolo-dihydroisoquinoline derivatives as pde10 inhibitors |
| 04/05/2006 | EP1641456A2 Gaboxadol for treating depression and other affective disorders |
| 04/05/2006 | EP1641455A1 Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors |
| 04/05/2006 | EP1641454A1 Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors |
| 04/05/2006 | EP1641451A2 Method for photodynamic inactivation of pathogens using ala |
| 04/05/2006 | EP1641450A2 Use of plasma membrane calcium atpase (pmca) inhibitors for inhibiting sperm mobility |
| 04/05/2006 | EP1641449A1 Cancer treatment with epothilones |
| 04/05/2006 | EP1641448A2 Mixed zeaxanthin ester concentrate and uses thereof |
| 04/05/2006 | EP1641447A2 Method of purifying pravastatin |
| 04/05/2006 | EP1641446A1 Pharmaceutical compositions including an antihistamine and a stimulant and use thereof |
| 04/05/2006 | EP1641445A1 Use of alverine, alone or in combination with a tricyclic antidepressant or an antidepressant which is a specific inhibitor of serotonin reuptake for treatment of depression |
| 04/05/2006 | EP1641444A1 Treatment of muscle fatigue |
| 04/05/2006 | EP1641443A1 Cosmetic and/or pharmaceutical compositions comprising dimthylsulphone for the cure and prevention of irritation, inflammation and cutaneous erythema |
| 04/05/2006 | EP1641442A1 Use of osmolytes obtained from extremophilic bacteria for the production of inhalable medicaments for the prophylaxis and treatment of pulmonary and cardiovascular diseases and an inhalation device comprising an osmolyte as active agent component |
| 04/05/2006 | EP1641441A2 Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer |
| 04/05/2006 | EP1641440A1 Tablet comprising fluvastatin and carmellose calcium |
| 04/05/2006 | EP1641437A1 The solid dispersion of tacrolimus |
| 04/05/2006 | EP1641436A1 Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
| 04/05/2006 | EP1641433A1 Novel dermatological and/or cosmetologic hydrating and anti-irritation compositions |
| 04/05/2006 | EP1641423A2 Benzodiazepine cgrp receptor antagonists |
| 04/05/2006 | EP1641391A2 Porphyrins and metalloporphyrins for inhibiting heme iron uptake |
| 04/05/2006 | EP1641359A1 Compositions and food products from oat |
| 04/05/2006 | EP1641354A1 Use of isomalt (mixture of 1,6 gps and 1,1 gpm) as a prebiotic for the production of a medicament used for the treatment of intestinal diseases, among other things |
| 04/05/2006 | EP1641352A1 Compositions for improved oxidative status in companion animals |
| 04/05/2006 | EP1641351A1 Compositions and methods for decreasing age-related deterioration in metal activities in companion animals |
| 04/05/2006 | EP1596875A4 Tertiary amine functional complex polyester polymers and methods of production and use |
| 04/05/2006 | EP1572152A4 Liposomal analgesic formulation and use |
| 04/05/2006 | EP1560503A4 Soluble isoflavone compositions |
| 04/05/2006 | EP1526849B1 Topical formulations containing ketoprofen stabilised with sulisobenzone |
| 04/05/2006 | EP1524975B1 Improved transdermal delivery system for the administration of rotigotine |
| 04/05/2006 | EP1485084B1 Use of an l-ascorbic acid salt to prepare a pharmaceutical composition for ophthalmic topical use capable of improving the level of l-ascorbic acid in the eye |
| 04/05/2006 | EP1465636A4 Compositions and methods for enhancing corticosteriod delivery |
| 04/05/2006 | EP1453777B1 Functionalized higher diamondoids |
| 04/05/2006 | EP1450822A4 Polymeric thiol-linked prodrugs |
| 04/05/2006 | EP1438104B1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 04/05/2006 | EP1435235B1 Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 04/05/2006 | EP1411960B1 Fortified rice bran food product for promoting cardiovascular health |
| 04/05/2006 | EP1409494B1 Stabilized derivatives of ascorbic acid -3- phosphate |
| 04/05/2006 | EP1392308B1 Ophthalmically acceptable compositions comprising an alpha-2-adrenergic agonist and a fatty acid |
| 04/05/2006 | EP1372680B1 Biologically active aqueous fraction of an extract obtained from a mangrove plant salvadora persica l |
| 04/05/2006 | EP1370544B1 Nitric oxide donors based on metallic centres |
| 04/05/2006 | EP1334105B1 Process for the preparation of crystalline n-formimidoyl thienamycin monohydrate (imipenem monohydrate) |
| 04/05/2006 | EP1333848B1 Phyllanthus-derived compounds for the prevention and/or treatment of diseases associated with a retrovirus |
| 04/05/2006 | EP1333805B1 Cosmetic method of treating skin |
| 04/05/2006 | EP1331005B1 Medicinal compositions for concominant use as anticancer atent |
| 04/05/2006 | EP1330249B1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 04/05/2006 | EP1320361A4 Method for reducing exacerbations associated with copd |
| 04/05/2006 | EP1320355B1 System for delivering a tobramycin formulation |
| 04/05/2006 | EP1317261B1 Preparation for treating diseases of bone tissues comprising hydroxyapatite |
| 04/05/2006 | EP1307197B1 Compositions for the treatment of cancer comprising a topoisomerase inhibitor and thalidomide |
| 04/05/2006 | EP1305319B1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 04/05/2006 | EP1300398B1 Propane-1,3-dione derivatives |
| 04/05/2006 | EP1294720B1 Non-nucleoside reverse transcriptase inhibitors |
| 04/05/2006 | EP1294359B1 Process for preparing and harvesting crystalline particles |
| 04/05/2006 | EP1289504B1 Neurotoxin implant |
| 04/05/2006 | EP1286671B1 Compositions for the treatment of colorectal cancer comprising thalidomide and irinotecan |
| 04/05/2006 | EP1280524B1 Methods and compositions for modulating alpha adrenergic receptor activity |
| 04/05/2006 | EP1245564B1 Benzamidine derivatives |
| 04/05/2006 | EP1244668B1 Purine derivatives, process for their preparation and use thereof |
| 04/05/2006 | EP1244667B1 Cyclohexene nucleic acids |
| 04/05/2006 | EP1239828B1 Use of cationic compounds |
| 04/05/2006 | EP1235581B1 Use of ribose to prevent cramping and soreness in muscles |
| 04/05/2006 | EP1198235A4 Method of promoting bone growth with hyaluronic acid and growth factors |
| 04/05/2006 | EP1173427B1 Hydroxamic acid derivative |